https://www.nxtpsychedelics.com/news/articles/public-companies/algernon-pharmaceuticals-enters-into-a-clinical-trial-agreement-with-yale-university-for-a-dmt-phase-2-depression-study/
Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study